According to the Jiangnan New Materials announcement, the cumulative deviation value of the closing price increase of the company's stock exceeded 20% for 3 consecutive trading days from August 4 to August 6, 2026, which was an abnormal fluctuation. After self-inspection, the company's production and operation were normal. Except for matters relating to the issuance of A-shares to specific targets in 2026, no significant information should have been disclosed or not disclosed. The offering still requires review by the shareholders' meeting, review by the Shanghai Stock Exchange, and approval from the Securities Regulatory Commission. There is uncertainty, and investors are reminded to be aware of the risks.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.